{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:09:51Z","timestamp":1784668191054,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T00:00:00Z","timestamp":1656460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["UM 2013-6229"],"award-info":[{"award-number":["UM 2013-6229"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016244","name":"Health Foundation Limburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016244","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.crad.2022.06.010","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T08:16:07Z","timestamp":1657872967000},"page":"e732-e740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid 18F-FDG PET\/MRI in clinically node-positive breast cancer patients: a pilot study"],"prefix":"10.1016","volume":"77","author":[{"given":"C.M.","family":"de Mooij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Samiei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mitea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.I.","family":"Lobbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.S.","family":"Kooreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Heuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.G.H.","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.A.","family":"van Nijnatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.crad.2022.06.010_bib1","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.annonc.2020.09.010","article-title":"5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)","volume":"31","author":"Cardoso","year":"2020","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.crad.2022.06.010_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO Guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.crad.2022.06.010_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"issue":"12","key":"10.1016\/j.crad.2022.06.010_bib4","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.crad.2022.06.010_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.21535","article-title":"Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection","volume":"102","author":"Ashikaga","year":"2010","journal-title":"J Surg Oncol"},{"issue":"24","key":"10.1016\/j.crad.2022.06.010_bib6","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.crad.2022.06.010_bib7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/SLA.0000000000004356","article-title":"Diagnostic performance of noninvasive imaging for assessment of axillary response after neoadjuvant systemic therapy in clinically node-positive breast cancer: a systematic review and meta-analysis","volume":"273","author":"Samiei","year":"2021","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.crad.2022.06.010_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-021-06283-8","article-title":"Predicting pathological axillary lymph node status with ultrasound following neoadjuvant therapy for breast cancer","volume":"189","author":"Skarping","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.crad.2022.06.010_bib9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00330-018-5720-8","article-title":"What is the diagnostic performance of 18-FDG-PET\/MR compared to PET\/CT for the N- and M- staging of breast cancer?","volume":"29","author":"Botsikas","year":"2019","journal-title":"Eur Radiol"},{"issue":"12","key":"10.1016\/j.crad.2022.06.010_bib10","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1007\/s00259-020-04801-2","article-title":"Prospective evaluation of whole-body MRI and (18)F-FDG PET\/MRI in N and M staging of primary breast cancer patients","volume":"47","author":"Bruckmann","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.crad.2022.06.010_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-017-3849-3","article-title":"Integrated (18)F-FDG PET\/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy","volume":"45","author":"Cho","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"10.1016\/j.crad.2022.06.010_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/RLU.0000000000001684","article-title":"Multiparametric evaluation of treatment response to neoadjuvant chemotherapy in breast cancer using integrated PET\/MR","volume":"42","author":"Wang","year":"2017","journal-title":"Clin Nucl Med"},{"issue":"6","key":"10.1016\/j.crad.2022.06.010_bib13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2967\/jnumed.112.105338","article-title":"Oncologic PET\/MRI, part 1: tumours of the brain, head and neck, chest, abdomen, and pelvis","volume":"53","author":"Buchbender","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2022.06.010_bib14","doi-asserted-by":"crossref","first-page":"A26","DOI":"10.1016\/j.ejrad.2017.05.006","article-title":"PET\/MRI of the breast","volume":"94","author":"Plecha","year":"2017","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.crad.2022.06.010_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00259-017-3823-0","article-title":"Added value of dedicated axillary hybrid 18F-FDG PET\/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.","volume":"45","author":"van Nijnatten","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.crad.2022.06.010_bib16","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13244-015-0404-2","article-title":"The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review","volume":"6","author":"Kuijs","year":"2015","journal-title":"Insights Imaging"},{"issue":"18","key":"10.1016\/j.crad.2022.06.010_bib17","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1016\/j.ejca.2010.07.034","article-title":"Detection of extra-axillary lymph node involvement with FDG PET\/CT in patients with stage II\u2013III breast cancer","volume":"46","author":"Aukema","year":"2010","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.crad.2022.06.010_bib18","doi-asserted-by":"crossref","first-page":"W641","DOI":"10.2214\/AJR.10.4889","article-title":"Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? Evaluation of an extended protocol in an initial prospective study","volume":"196","author":"Baltzer","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.crad.2022.06.010_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ejrad.2010.10.005","article-title":"Diagnostic value of chemical shift artifact in distinguishing benign lymphadenopathy","volume":"80","author":"Farshchian","year":"2011","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.crad.2022.06.010_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/RLI.0b013e318277f056","article-title":"Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study","volume":"48","author":"Schipper","year":"2013","journal-title":"Invest Radiol"},{"issue":"11","key":"10.1016\/j.crad.2022.06.010_bib22","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s00259-017-3745-x","article-title":"Hybrid (18)F-FDG PET\/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy","volume":"44","author":"Goorts","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.crad.2022.06.010_bib23","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2967\/jnumed.120.247882","article-title":"Head-to-head evaluation of (18)F-FES and (18)F-FDG PET\/CT in metastatic invasive lobular breast cancer","volume":"62","author":"Ulaner","year":"2021","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.crad.2022.06.010_bib24","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","article-title":"Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer","volume":"20","author":"Hieken","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.crad.2022.06.010_bib25","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1097\/RLU.0000000000001191","article-title":"Prognostic role of early and end-of-neoadjuvant treatment 18F-FDG PET\/CT in patients with breast cancer","volume":"41","author":"Vicente","year":"2016","journal-title":"Clin Nucl Med"},{"issue":"4","key":"10.1016\/j.crad.2022.06.010_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15040","article-title":"Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation","volume":"15","author":"Cooper","year":"2011","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.crad.2022.06.010_bib27","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/jmri.27246","article-title":"PET\/CT and MRI for identifying axillary lymph node metastases in breast cancer patients: systematic review and meta-analysis","volume":"52","author":"Zhang","year":"2020","journal-title":"J Magn Reson Imaging"},{"issue":"12","key":"10.1016\/j.crad.2022.06.010_bib28","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.ejrad.2016.10.030","article-title":"Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients","volume":"85","author":"van Nijnatten","year":"2016","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.crad.2022.06.010_bib29","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1007\/s00330-020-06760-6","article-title":"Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer","volume":"30","author":"Samiei","year":"2020","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.crad.2022.06.010_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12880-020-00449-4","article-title":"Diagnostic performance of standard breast MRI compared to dedicated axillary MRI in the evaluation of axillary lymph node","volume":"20","author":"Ha","year":"2020","journal-title":"BMC Med Imaging"},{"issue":"2","key":"10.1016\/j.crad.2022.06.010_bib31","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1148\/radiol.14141167","article-title":"Diagnostic performance of dedicated axillary T2- and diffusion-weighted MRI for nodal staging in breast cancer","volume":"275","author":"Schipper","year":"2015","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.crad.2022.06.010_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiol.11110639","article-title":"Accuracy of unenhanced MRI in the detection of axillary lymph node metastasis: study of reproducibility and reliability","volume":"262","author":"Scaranelo","year":"2012","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.crad.2022.06.010_bib33","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/bjs.10555","article-title":"Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy","volume":"104","author":"Koolen","year":"2017","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.crad.2022.06.010_bib34","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1245\/s10434-018-6404-y","article-title":"Major reduction in axillary lymph node dissections after neoadjuvant systemic therapy for node-positive breast cancer by combining PET\/CT and the MARI procedure","volume":"25","author":"van der Noordaa","year":"2018","journal-title":"Ann Surg Oncol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926022003154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926022003154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:12:37Z","timestamp":1762114357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926022003154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0009926022003154"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2022.06.010","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid 18F-FDG PET\/MRI in clinically node-positive breast cancer patients: a pilot study","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2022.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}